Edwin K. Yager, Ph.D.

 

 

 

 

Personal

Professional

Qualifications

Availability

Confidentiality

 

Therapeutic 

Philosophy

Contact Me

Directions

Home

Presentations

 

 

 

 

 

 

 

 

 

 

 

 
 
 
 
 
 
 
 
 

Subliminal Therapy Success Rates

 

Study of the Success Rates of 73 Patients

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Data processing:

The data was quantified by assuming each continuum to represent 0-to-10, recording the value marked thereon, and averaging the scores.  The averaged before-and-after scores were then evaluated using the Effect Size computation of Cohen’s d and r.

 

Results: 

 

The results of the study are summarized in Table 1.  The overall Cohen’s d is 2.11, r = 0.858, n = 120. 

 

Table 1 -- Effectiveness of Subliminal Therapy 

 

 

Diagnosis

 

Effect Size

 

Improvement

 

Average

Tx hours

 

n

Cohen’s d

Correlation r

 

 

 

 

 

 

Addiction

5.25

0.934

92%

2.2

6

Anxiety Disorders

 

 

 

 

 

     General Anxiety D

2.62

0.794

92%

4.2

22

     Social Anxiety

2.07

0.719

84%

3.0

48

     Obsessive Compulsive D

1.16

0.500

68%

1.8

9

     Panic D w/o Agoraphobia

1.44

0.586

74%

2.3

8

     Phobic D

1.35

0.560

91%

1.4

9

Mood D

2.07

0.719

79%

3.1

18

Physical D

1.55

0.614

66%

3.3

19

Sexual D

2.70

0.804

84%

6.8

5

Sleep D

2.26

0.795

84%

3.1

8

Other D

2.75

0.809

84%

3.0

16

 

 

 

 

 

 

Overall average

2.11

0.858

82%

3.4

Total 120

 

 

 

Expansion of the details of the above data, in addition to newly added subjects, is available by request to doc@docyager.com

Limitations: 

The data obtained in this study was derived exclusively from patients who were treated by the author in his private practice.  Therefore, the data may not accurately represent the results of treatment by Subliminal Therapy if conducted by others.       

 

While some follow-up data is available, which thus far confirms the results reported above, there has not yet been adequate follow up to validate results.  A concerted effort to obtain this data was begun in July 2010. 

 

OTHER THERAPIES

 

A search was conducted to identify studies that would provide data with which to compare the efficacy of ST with other protocols. Only a few of the studies identified included objective data, most reported in verbal terms with expressions such as “significantly significant improvement.”  Table 2 shows the results of those studies that reported data in a comparable form, and serves to provide data for the comparison.  

Table 2 – Success Rates of Other Therapies 

Study

Results

 

As quoted in Pignott et al, Turner et al (2008) compared the Effect Size derived from the FDA repository to that from 51 published studies on antidepressant treatment.

Weighted Means Effect Sizes

FDA data set            0.31

Published studies     0.41

 

Roy-Byrne et al (2004) conducted a trial of CBT v. medications  for Panic Disorder involving 6 treatment sessions with up to 6 follow-up sessions.

At 3 months:

    CBT was 46% vs. medications at 27%, n = 232

At 12 months:

    CBT was 63% vs. medications at 38%

 

Rector et al (2009) examined the efficacy of CBT for OCD in patients with MDD.

F = 12.33, df = 1.27, P = 0.002, d = 0.77  n = 27

 

 

Norton et al, (2007) conducted a meta-analytic review of 108 trials of CBT across the Anxiety Disorders.

 

Pre- Post

Post- FU

PD/A

1.37 (6)

0.08 (5)

SAD

1.03 (3)

0.21 (3)

OCD

1.16 (7)

0.08 (3)

GAD

2.06 (6)

0.29 (5)

PTSD

2.23 (3)

0.54 (3)

Overall

1.67

0.22

 

Hendricks et al, (2008) examined the efficacy of CBT for late-life anxiety disorders.

SMD=-0.51 (95% CI: -0.81), P< 0.001

Seven papers reviewed with n = 297

 

Rezvan et al (2008) compared the effectiveness of CBT with CBT and interpersonal therapy combined in the treatment of generalized anxiety disorder.

CBT               Cohen’s d = 2.700, r = 0.804, n = 36

CBT + IPT     Cohen’s d = 2.848, r = 0.818

Control           Cohen’s d = 1.315, r = 0.549

                        

Hynninen et al (2010) examined the effect of CBT in groups for co-morbid, clinically significant anxiety and depression on COPD outpatients.

Anxiety          Effect Size = 1.1,  n = 26

Depression     Effect Size = 0.9 

 

 

Keller et al (2000) compared nefazodone with CBT and the combination of nefazodone plus CBT in the treatment of chronic depression

Nefazodone      55%,   n = 681

CBT                  52%

Combination     85%

 

Coventry and Gellaty (2007) looked at CBT, given with exercise training and education, in the  treatment of moderate anxiety and depression in COPD patients.

Anxiety       -21.39 (95% Cls -22.19, -20.59)

Depression  -20.86 (95% Cls -21.61, -20.11)

 

 

Data on length of treatment by CBT was particularly difficult to identify.  As quoted by Gale Thompson on Healthline:, Like behavior therapy, cognitive behavior therapy tends to be short-term (often between 10 and 20 sessions), …”  http://www.healthline.com/galecontent/cognitive-behavior-therapy#cognitivebehaviortherapy

 

Conclusions:

 

Subliminal Therapy demonstrates an unusually high Effect Size over an unusually wide range of presenting problems, physical as well as mental.  ST demonstrated an overall Effect Size of 2.11 with CBT demonstrating a range of 1.19 TO 1.28.  ST is significantly more efficacious than CBT in terms of effectiveness and in efficiency as well.

               

 

 

 

 A question is sometimes raised about the limited number of Depression cases.  We speak of treating depression as though it is a separate and distinct malady.  In fact, depression seldom stands alone as a presenting problem; it most often accompanies other presenting problems.  If a patient is anxious, there is high probability that depression is also present.  If a patient is obsessive, phobic, dissociated, pain-ridden, or experiencing any other serious problem, depression is almost certainly present.  In these cases, depression is a symptom of another problem and will cease to exist when the basic problem is resolved.  A high percentage of all of the reported cases in the table have a significant depressive component.

 

 Should you wish a more expansive presentation of details of the data summarized above,  click here.

 

 A full, updated table of the results of this research, detailing each patient with each presenting problem, is available to interested researchers upon request to doc@docyager.com.

 

 

 

 


       

 

 

 

 

 

 

 

  

 

 

Beginning in August of 2008, I have accumulated data to objectively evaluate the effectiveness and efficiency of ST. The data formalized in following paragraphs were derived from patient-completed inventories obtained in my private practice in San Diego, California.

 

Methods:

Subjects: 

The subjects of this study were all patients in my private practice. All 73 patients were adults with a mean age of 38 years, most of whom presented more than one problem. Thirty patients were male, 42 were female. Of the 120 problems reported here, 50 were presented by males and 70 were presented by females. Thirteen patients were excluded from the study because of incomplete treatment.

 

Procedure: 

In each case, the initial session was devoted to history and evaluation, and all subjects were instructed in the self-use of hypnosis.  All were provided with a copy of Subliminal Therapy: Utilizing the Unconscious Mind (Yager 1985), and were instructed to read it prior to the next appointment. Subjects were typically seen 1-2 times per week for one-hour sessions and all were treated by ST.

 

Data collection: 

Patients were asked to complete a brief inventory form at the initial session, again at the conclusion of treatment and (currently in execution) as a follow up. The form used was a one-page inventory of the effects the presenting problem was having on the patient’s life.  The following questions were asked and the patient was requested to indicate the degree of effect by marking on a continuum representing “Not at all” to “Severe.” In the event more than one problem was presented, a separate form was used for each. 

 

To what extent are the symptoms present in your life?

To what extent has the above problem interfered with your social life?

To what extent has the above problem interfered with your family life?

To what extent has the above problem interfered with your sexual life?

To what extent has the above problem interfered with your spiritual life?

To what extent has the above problem interfered with your memory?

To what extent has the above problem interfered with your sleep?

To what extent has the above problem interfered with your appetite?

To what extent has the above problem interfered with your work life?

To what extent has the above problem interfered with your ability to concentrate?

To what extent has the above problem been a cause of personal distress?

To what extent has the above problem caused you to feel depressed?

To what extent has the above problem caused you to feel anxious?

To what extent has the above problem caused physical problems?

To what extent has the above problem caused any other problem/s?

          If your response is affirmative, what is that problem?